Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery Indian Medical PG Practice Questions and MCQs

Question 431: All of the following are associated with Caroli's disease, EXCEPT:

A. Biliary atresia (Correct Answer)
B. Cholangiocarcinoma
C. Biliary lithiasis
D. Biliary abscess

Explanation: **Explanation:** **Caroli’s Disease** is a rare congenital disorder characterized by multifocal, segmental saccular dilatation of the large intrahepatic bile ducts. It is classified as a **Todani Type V choledochal cyst**. **Why Biliary Atresia is the Correct Answer:** Biliary atresia involves the fibro-obliterative destruction of the extrahepatic biliary tree, leading to obstruction. In contrast, Caroli’s disease is a condition of **ductal ectasia (dilatation)**. There is no established pathophysiological link between the two. Caroli’s disease is more commonly associated with **Autosomal Recessive Polycystic Kidney Disease (ARPKD)** and congenital hepatic fibrosis (known as Caroli’s Syndrome). **Analysis of Incorrect Options:** * **Biliary Lithiasis:** Stasis of bile within the dilated intrahepatic saccules leads to the formation of "sludge" and hepatolithiasis (intrahepatic stones) in up to 95% of patients. * **Biliary Abscess:** Recurrent bouts of bacterial cholangitis due to bile stasis and stone formation frequently progress to the formation of multiple intrahepatic biliary abscesses. * **Cholangiocarcinoma:** Chronic inflammation and irritation of the biliary epithelium pose a significant premalignant risk. Patients with Caroli’s disease have a 7–15% lifetime risk of developing cholangiocarcinoma. **NEET-PG High-Yield Pearls:** * **Genetics:** Associated with the **PKHD1** gene mutation. * **Imaging Gold Standard:** MRCP is the investigation of choice; it shows the **"Central Dot Sign"** (portal vein branches surrounded by dilated bile ducts) on CT/MRI. * **Classification:** Caroli’s Disease (limited to bile ducts) vs. Caroli’s Syndrome (bile duct dilatation + congenital hepatic fibrosis/portal hypertension). * **Treatment:** Localized disease is treated with lobectomy; diffuse disease requires liver transplantation.

Question 432: Bile strictures are most commonly seen in which of the following conditions?

A. Cholelithiasis (Correct Answer)
B. Malignancy
C. Post-operative state
D. Worm infestation

Explanation: **Explanation:** The correct answer is **Cholelithiasis (Option A)**. While post-operative injuries are a frequent cause of *iatrogenic* strictures, the question asks for the most common underlying condition associated with bile duct strictures globally. **1. Why Cholelithiasis is correct:** Chronic cholelithiasis and recurrent cholecystitis lead to persistent inflammation of the gallbladder and the surrounding Calot’s triangle. This chronic inflammatory process results in **fibrosis**, which can involve the common hepatic or common bile duct, leading to stricture formation. A classic example is **Mirizzi Syndrome**, where a stone impacted in the cystic duct or gallbladder neck causes extrinsic compression and subsequent stricture/fistula of the common hepatic duct. **2. Why other options are incorrect:** * **Malignancy (Option B):** While malignant strictures (e.g., Cholangiocarcinoma or Pancreatic cancer) are clinically significant and often present with painless jaundice, they are statistically less common than inflammatory strictures arising from gallstone disease. * **Post-operative state (Option C):** This is the most common cause of *iatrogenic* strictures (especially following laparoscopic cholecystectomy). However, in a general epidemiological context, the inflammatory sequelae of cholelithiasis remain more prevalent. * **Worm infestation (Option D):** Parasites like *Ascaris lumbricoides* or *Clonorchis sinensis* can cause biliary obstruction and strictures (Oriental Cholangiohepatitis), but these are geographically restricted and less common than gallstone-related pathology. **Clinical Pearls for NEET-PG:** * **Most common cause of iatrogenic stricture:** Laparoscopic Cholecystectomy (usually due to misidentification of anatomy). * **Investigation of choice:** **MRCP** (Non-invasive, defines the anatomy proximal and distal to the stricture). * **Gold Standard for treatment:** Roux-en-Y Hepaticojejunostomy. * **Bismuth Classification** is used to grade the level of biliary strictures based on the distance from the biliary confluence.

Question 433: What is the best treatment for refractory ascites?

A. Atriovenous shunt
B. Transjugular intrahepatic portosystemic shunt (TIPS) (Correct Answer)
C. Furosemide with low-volume paracentesis
D. Distal splenorenal shunt

Explanation: **Explanation:** **Refractory ascites** is defined as ascites that cannot be mobilized by medical therapy (diuretics and sodium restriction) or that recurs rapidly after therapeutic paracentesis. 1. **Why TIPS is the Correct Answer:** The underlying pathophysiology of ascites in cirrhosis is portal hypertension. **TIPS** is a non-surgical, radiologic procedure that creates a low-resistance channel between the hepatic vein and the intrahepatic portion of the portal vein. By effectively decompressing the portal system, it addresses the root cause of fluid sequestration. Clinical trials have shown that TIPS is superior to repeated Large Volume Paracentesis (LVP) for the long-term management of refractory ascites and improves transplant-free survival. 2. **Analysis of Incorrect Options:** * **Atriovenous shunt (e.g., LeVeen or Denver shunt):** These were historically used but are now largely obsolete due to high rates of complications, including shunt occlusion, infection, and disseminated intravascular coagulation (DIC). * **Furosemide with low-volume paracentesis:** This is the treatment for *uncomplicated* ascites. By definition, "refractory" ascites has failed medical management with diuretics. * **Distal splenorenal shunt (Warren Shunt):** This is a selective surgical shunt used primarily to prevent variceal bleeding. It does not effectively decompress the sinusoidal hypertension responsible for ascites and is associated with higher surgical morbidity compared to TIPS. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Liver Transplantation is the definitive treatment for refractory ascites. * **TIPS Contraindications:** Absolute contraindications include congestive heart failure (due to increased venous return), severe pulmonary hypertension, and uncontrolled systemic infection. * **Complication of TIPS:** The most common complication is **Hepatic Encephalopathy** (occurring in ~30% of patients) due to the bypassing of hepatic detoxification. * **SAAG Score:** A Serum-Ascites Albumin Gradient **>1.1 g/dL** indicates portal hypertension.

Question 434: What is the investigation of choice for choledochal cyst?

A. Graham chole's test
B. MRCP (Correct Answer)
C. ERCP
D. USG

Explanation: **Explanation:** **Choledochal cysts** are congenital cystic dilatations of the biliary tree. The primary goal of imaging is to delineate the anatomy of the cyst, its extent, and the presence of an **Anomalous Pancreaticobiliary Duct Junction (APBDJ)**, which is frequently associated with this condition. * **Why MRCP is the Investigation of Choice (IOC):** Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive, radiation-free modality that provides excellent anatomical detail of the entire biliary tree and pancreatic duct. It has a high sensitivity for detecting APBDJ and is preferred over invasive methods, especially in the pediatric population. **Analysis of Other Options:** * **USG (Ultrasound):** This is the **initial/screening investigation**. While it can detect a cyst, it is operator-dependent and often fails to visualize the distal common bile duct or the pancreaticobiliary junction clearly. * **ERCP (Endoscopic Retrograde Cholangiopancreatography):** Historically the "gold standard" for biliary anatomy, it is now reserved for **therapeutic interventions** (e.g., stone removal or stenting) due to its invasive nature and risks like pancreatitis. * **Graham Cole’s Test:** An obsolete oral cholecystography technique used historically to visualize the gallbladder; it has no role in modern biliary imaging. **High-Yield Clinical Pearls for NEET-PG:** * **Classification:** Todani’s Classification (Type I is the most common; Type V is Caroli’s Disease). * **Classic Triad:** Jaundice, right upper quadrant pain, and a palpable mass (seen in only 20% of cases). * **Treatment:** Complete surgical excision of the cyst with **Roux-en-Y Hepaticojejunostomy** (to prevent the high risk of cholangiocarcinoma). * **Gold Standard:** While MRCP is the IOC, **Intraoperative Cholangiography (IOC)** remains the most definitive way to define anatomy during surgery.

Question 435: Mirizzi syndrome is characterized by all the following except:

A. Gallstone ulcerating into the common duct
B. Impacted stone in the cystic duct
C. Severe pericholecystic inflammation
D. Obstructive jaundice (Correct Answer)

Explanation: ### Explanation **Mirizzi Syndrome** is a rare complication of chronic cholelithiasis where a gallstone becomes impacted in the **cystic duct** or the **neck of the gallbladder (Hartmann’s pouch)**. This causes extrinsic compression of the **Common Hepatic Duct (CHD)**, leading to obstructive jaundice. #### Why "Obstructive Jaundice" is the Correct Answer (The "Except" Factor) This question is a classic "except" type. In many standard surgical textbooks and clinical practice, **Obstructive Jaundice is a hallmark clinical feature** of Mirizzi Syndrome. However, in the context of this specific MCQ (often sourced from older paper patterns or specific examiners), it is sometimes argued that jaundice is a *consequence* or a *symptom* rather than a defining *pathological characteristic* of the syndrome itself. *Note: In a modern clinical context, all four options are technically true. However, if forced to choose the "least accurate" defining feature, jaundice is a clinical sign, whereas the others describe the underlying pathology.* #### Analysis of Other Options: * **Option B & C:** The pathophysiology begins with an **impacted stone in the cystic duct (B)**. This triggers **severe pericholecystic inflammation (C)**, which leads to the external compression of the adjacent CHD. * **Option A:** Over time, the pressure necrosis from the stone causes it to **ulcerate into the common duct (A)**, forming a cholecystobiliary fistula (Csendes Classification Types II–IV). #### Clinical Pearls for NEET-PG: * **Csendes Classification:** * **Type I:** Simple extrinsic compression of CHD. * **Type II:** Fistula involving <1/3 of the CHD circumference. * **Type III:** Fistula involving 1/3 to 2/3 of the CHD circumference. * **Type IV:** Total destruction of the CHD wall. * **Diagnostic Clue:** On ERCP/MRCP, look for a smooth, lateral extrinsic compression of the CHD. * **Surgical Risk:** There is a high risk of **bile duct injury** during cholecystectomy due to distorted anatomy and dense adhesions. * **Association:** Mirizzi syndrome is associated with an increased risk of **gallbladder cancer**.

Question 436: Which of the following is a known complication of a choledochal cyst?

A. Choledochal cysts primarily manifest in adulthood.
B. Surgical excision of choledochal cysts is rarely performed.
C. Choledochal cysts typically present with rapidly progressing jaundice.
D. Malignant transformation into carcinoma is a potential complication of choledochal cysts. (Correct Answer)

Explanation: **Explanation:** Choledochal cysts are congenital cystic dilatations of the biliary tree. The most significant and feared complication of these cysts is **malignant transformation**, primarily into **cholangiocarcinoma**. This risk increases with age, reaching up to 15-30% in adults. The pathogenesis is linked to an anomalous pancreaticobiliary ductal junction (APBDJ), which allows the reflux of pancreatic enzymes into the biliary tree, causing chronic inflammation, epithelial dysplasia, and eventually neoplasia. **Analysis of Options:** * **Option A is incorrect:** While they can be diagnosed at any age, approximately 80% of choledochal cysts manifest in **infancy or childhood**. * **Option B is incorrect:** Complete **surgical excision** (cystectomy) with Roux-en-Y hepaticojejunostomy is the **standard of care**. Simple drainage procedures are avoided as they do not eliminate the risk of malignancy. * **Option C is incorrect:** The classic presentation is a **triad** of intermittent jaundice, abdominal pain, and a palpable right upper quadrant mass. Rapidly progressing jaundice is more characteristic of acute biliary obstruction or malignant biliary tumors. **High-Yield Pearls for NEET-PG:** * **Todani Classification:** Type I (Saccular/fusiform dilatation of CBD) is the most common (80-90%). Type V is known as **Caroli’s Disease**. * **Malignancy Risk:** Highest in Type I and Type IV cysts. * **Management:** Complete excision is mandatory because even after surgery, there remains a small residual risk of cancer in the remaining biliary tree. * **Diagnosis:** Ultrasound is the initial screening tool; **MRCP** is the gold standard for defining the anatomy.

Question 437: Which part of the intrahepatic bile duct is involved in Type 2 cholangiocarcinoma?

A. Division of both ducts and not extending outside (Correct Answer)
B. Common hepatic duct only
C. Secondary hepatic ducts
D. Extends beyond hilum

Explanation: This question refers to the **Bismuth-Corlette Classification**, which is the standard system used to categorize Hilar Cholangiocarcinoma (Klatskin tumors) based on the anatomical extent of the tumor within the biliary tree. ### **Explanation of the Correct Answer** **Type 2** cholangiocarcinoma involves the **confluence of the right and left hepatic ducts** (the primary division). By definition, the tumor involves the junction of the ducts but does not extend into the secondary (segmental) branches. Therefore, Option A is correct as it describes the involvement of the division of both ducts without further extension. ### **Analysis of Incorrect Options** * **Option B (Common hepatic duct only):** This describes **Type 1** tumors, which are located in the common hepatic duct distal to the biliary confluence. * **Option C (Secondary hepatic ducts):** This describes **Type 3 or Type 4** tumors. Type 3 involves the confluence and extends into either the right (3a) or left (3b) secondary radicals. Type 4 involves the confluence and extends into secondary radicals on **both** sides or is multicentric. * **Option D (Extends beyond hilum):** This is a general description and does not specifically define Type 2. Extension beyond the hilum into secondary radicals would upgrade the classification to Type 3 or 4. ### **NEET-PG High-Yield Pearls** * **Klatskin Tumor:** A tumor occurring at the junction of the right and left hepatic ducts. * **Bismuth-Corlette Summary:** * **Type 1:** Below the confluence. * **Type 2:** At the confluence. * **Type 3a:** Confluence + Right secondary radicals. * **Type 3b:** Confluence + Left secondary radicals. * **Type 4:** Confluence + Both right and left secondary radicals. * **Clinical Presentation:** Progressive painless jaundice with a palpable gallbladder (if the tumor is distal to the cystic duct) or a non-palpable gallbladder (if proximal to the cystic duct, as in Klatskin tumors). * **Imaging:** MRCP is the gold standard for mapping the extent of the tumor.

Question 438: Which of the following is the least common presentation of Hepatocellular Carcinoma (HCC)?

A. Pyrexia of Unknown Origin (PUO) (Correct Answer)
B. Abdominal Mass
C. Jaundice
D. Weakness

Explanation: **Explanation:** Hepatocellular Carcinoma (HCC) typically arises in the background of chronic liver disease or cirrhosis. While it can present with a wide array of symptoms, **Pyrexia of Unknown Origin (PUO)** is considered the **least common** presentation among the options provided. 1. **Why PUO is the correct answer:** Fever in HCC is usually a paraneoplastic manifestation or due to tumor necrosis. While it occurs in approximately 10–15% of cases, it is rarely the *sole* or primary presenting feature (PUO). Most patients present with more overt signs of malignancy or liver decompensation before a fever workup is initiated. 2. **Analysis of Incorrect Options:** * **Abdominal Mass:** This is a very common presentation, especially in non-cirrhotic patients or in regions where screening is not routine. A palpable, firm, irregular liver mass is a classic finding. * **Jaundice:** This occurs frequently due to underlying cirrhosis, biliary obstruction by the tumor, or extensive replacement of the liver parenchyma. * **Weakness:** General constitutional symptoms like fatigue, weight loss, and anorexia are the most common non-specific complaints in patients with any advanced malignancy, including HCC. **Clinical Pearls for NEET-PG:** * **Most common presentation:** Abdominal pain (right upper quadrant) and weight loss. * **Most common site of metastasis:** Lungs (hematogenous spread). * **Tumor Marker:** Alpha-fetoprotein (AFP) >400 ng/mL is highly suggestive, but it can be normal in up to 30% of cases. * **Triad of HCC:** Rapidly enlarging liver, ascites (often blood-stained), and RUQ pain. * **Auscultation:** A **bruit or friction rub** over the liver is a high-yield physical sign specific to HCC.

Question 439: What is the recommended timing for performing cholangiography with a T-tube after cholecystectomy?

A. 1-5 days
B. 7-10 days (Correct Answer)
C. 10-14 days
D. 15-20 days

Explanation: **Explanation:** The correct timing for a postoperative T-tube cholangiogram is **7–10 days** after surgery. The primary medical rationale for this delay is to allow sufficient time for the **maturation of the fibrous tract** around the T-tube. If the tube is manipulated or if contrast is injected under pressure too early, there is a significant risk of bile leakage into the peritoneal cavity, leading to biliary peritonitis. By day 7–10, the tract is usually well-formed, and any residual stones in the common bile duct (CBD) can be safely identified before the tube is considered for removal. **Analysis of Options:** * **Option A (1-5 days):** Too early. The fibrous tract is immature, and the risk of bile leak is high. Additionally, postoperative edema at the Ampulla of Vater may still be present, leading to false-positive results (mimicking a stone). * **Option C & D (10-20 days):** While a cholangiogram can be performed during this window, it is not the *standard recommended timing*. Waiting until 14–21 days is typically reserved for the actual **removal** of the T-tube (to ensure a very firm tract), but the diagnostic imaging is ideally done sooner (day 7–10) to plan further management. **NEET-PG High-Yield Pearls:** * **Indications for T-tube:** Placed after a Common Bile Duct Exploration (CBDE) to provide drainage and a route for postoperative imaging. * **The "Water Test":** Before removing a T-tube, it is often clamped for 24 hours. If the patient develops pain or jaundice, it suggests distal obstruction (retained stone). * **Retained Stones:** If the cholangiogram shows a stone, the T-tube is left in place for **4–6 weeks** to allow the tract to mature enough for **Burhenne’s technique** (percutaneous stone extraction via the T-tube tract).

Question 440: The image shows stones found in the gall bladder. Which of the following conditions is associated with their formation?

A. Hypomotility of gall bladder
B. Accelerated cholesterol crystal nucleation
C. Hypersecretion of mucus
D. All of the above (Correct Answer)

Explanation: ***All of the above*** - All three mechanisms work synergistically in **cholesterol gallstone formation**: **bile stasis** from hypomotility, **nucleation** of cholesterol crystals, and **mucus hypersecretion** as a scaffold. - The pathogenesis involves **Admirand's triangle** disruption (cholesterol supersaturation) combined with these promoting factors leading to stone precipitation. *Hypomotility of gall bladder* - **Bile stasis** from reduced gallbladder contractility allows prolonged contact time for cholesterol precipitation and crystal growth. - While contributory, this alone is insufficient without **cholesterol supersaturation** and nucleating factors for stone formation. *Accelerated cholesterol crystal nucleation* - **Nucleation** is the initial step where cholesterol crystals form from supersaturated bile, but requires additional factors for stone development. - This process alone cannot sustain **stone growth** without bile stasis and mucus glycoproteins acting as a binding matrix. *Hypersecretion of mucus* - **Mucus glycoproteins** provide a nucleating scaffold and binding matrix essential for cholesterol crystal aggregation and stone formation. - Although crucial for stone development, mucus hypersecretion requires **cholesterol supersaturation** and stasis to be pathologically significant.

Practice by Chapter

Liver Anatomy and Physiology

Practice Questions

Benign Liver Lesions

Practice Questions

Liver Abscess

Practice Questions

Hepatocellular Carcinoma

Practice Questions

Metastatic Liver Disease

Practice Questions

Cirrhosis and Portal Hypertension

Practice Questions

Liver Trauma

Practice Questions

Cholelithiasis and Cholecystitis

Practice Questions

Choledocholithiasis

Practice Questions

Biliary Tract Tumors

Practice Questions

ERCP and Its Complications

Practice Questions

Liver Transplantation Basics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free